PL3202421T3 - Emulsje o/w zawierające semifluorowane alkany - Google Patents
Emulsje o/w zawierające semifluorowane alkanyInfo
- Publication number
- PL3202421T3 PL3202421T3 PL17159788T PL17159788T PL3202421T3 PL 3202421 T3 PL3202421 T3 PL 3202421T3 PL 17159788 T PL17159788 T PL 17159788T PL 17159788 T PL17159788 T PL 17159788T PL 3202421 T3 PL3202421 T3 PL 3202421T3
- Authority
- PL
- Poland
- Prior art keywords
- semifluored
- alkans
- emulsions containing
- emulsions
- semifluored alkans
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11150064 | 2011-01-04 | ||
| EP12700455.4A EP2661280B1 (en) | 2011-01-04 | 2012-01-03 | O/w-emulsions comprising semifluorinated alkanes |
| EP17159788.3A EP3202421B1 (en) | 2011-01-04 | 2012-01-03 | O/w-emulsions comprising semifluorinated alkanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3202421T3 true PL3202421T3 (pl) | 2018-10-31 |
Family
ID=43978091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12700455T PL2661280T3 (pl) | 2011-01-04 | 2012-01-03 | Emulsje typu olej w wodzie zawierające semifluorowane alkany |
| PL17159788T PL3202421T3 (pl) | 2011-01-04 | 2012-01-03 | Emulsje o/w zawierające semifluorowane alkany |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12700455T PL2661280T3 (pl) | 2011-01-04 | 2012-01-03 | Emulsje typu olej w wodzie zawierające semifluorowane alkany |
Country Status (15)
| Country | Link |
|---|---|
| US (6) | US20140004197A1 (pl) |
| EP (2) | EP3202421B1 (pl) |
| JP (1) | JP6073244B2 (pl) |
| KR (1) | KR101910213B1 (pl) |
| CN (1) | CN103313729B (pl) |
| AU (1) | AU2012204932B2 (pl) |
| BR (1) | BR112013016661B1 (pl) |
| CA (1) | CA2819988C (pl) |
| DK (2) | DK2661280T3 (pl) |
| ES (2) | ES2711760T3 (pl) |
| MX (1) | MX353154B (pl) |
| PL (2) | PL2661280T3 (pl) |
| PT (2) | PT3202421T (pl) |
| TR (2) | TR201808752T4 (pl) |
| WO (1) | WO2012093113A1 (pl) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2564502T3 (es) | 2010-03-17 | 2016-03-23 | Novaliq Gmbh | Composición farmacéutica para el tratamiento de la presión intraocular aumentada |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| JP6023181B2 (ja) | 2011-05-25 | 2016-11-09 | ノバリック ゲーエムベーハー | 爪に投与するための医薬組成物 |
| JP6039145B2 (ja) * | 2011-05-25 | 2016-12-07 | ノバリック ゲーエムベーハー | 半フッ化アルカンを基礎にした局所薬学的組成物 |
| CN104066442B (zh) | 2012-01-23 | 2018-05-18 | 诺瓦利克有限责任公司 | 基于半氟化烷烃的稳定蛋白质组合物 |
| MX360469B (es) | 2012-09-12 | 2018-11-05 | Novaliq Gmbh | Composiciones que comprenden mezclas de alcanos semifluorados. |
| DE202013012753U1 (de) | 2012-09-12 | 2019-03-04 | Novaliq Gmbh | Zusammensetzungen semifluorierter Alkane zur Verwendung in der Behandlung von Keratoconjunctivitis Sicca |
| GB2511028A (en) * | 2012-12-18 | 2014-08-27 | Univ Manchester Metropolitan | Nano emulsions, methods of forming the same and uses thereof |
| EP2783703A1 (en) * | 2013-03-25 | 2014-10-01 | B. Braun Melsungen AG | Semifluorocarbon compound containing contrast agent |
| WO2015011199A1 (en) | 2013-07-23 | 2015-01-29 | Novaliq Gmbh | Stabilized antibody compositions |
| KR20160145558A (ko) | 2014-03-03 | 2016-12-20 | 앙코르 비전, 인코포레이티드 | 리포산 콜린 에스테르 조성물 및 사용 방법 |
| CN120884568A (zh) | 2015-09-30 | 2025-11-04 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| ES2953837T3 (es) | 2015-09-30 | 2023-11-16 | Novaliq Gmbh | 2-perfluorobutil pentano para administración oftálmica |
| EP3442480B1 (en) | 2016-06-23 | 2019-10-02 | Novaliq GmbH | Topical administration method |
| US11684589B2 (en) | 2016-09-22 | 2023-06-27 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| JP6869336B2 (ja) | 2016-09-23 | 2021-05-12 | ノバリック ゲーエムベーハー | シクロスポリンを含む眼科用組成物 |
| DK3399962T3 (da) | 2016-12-23 | 2020-09-07 | Novaliq Gmbh | Oftalmisk sammensætning til behandling af tør øjensygdom |
| MX388460B (es) | 2017-04-21 | 2025-03-20 | Dermaliq Therapeutics Inc | Composiciones de yodo. |
| US10717691B2 (en) | 2017-05-05 | 2020-07-21 | Novaliq Gmbh | Process for the production of semifluorinated alkanes |
| CN110650734B (zh) | 2017-05-12 | 2024-11-15 | 诺瓦利克有限责任公司 | 治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物 |
| IL273531B2 (en) | 2017-09-27 | 2024-05-01 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
| EP3758676A1 (en) | 2018-03-02 | 2021-01-06 | Novaliq GmbH | Pharmaceutical compositions comprising nebivolol |
| JP2021522219A (ja) | 2018-04-27 | 2021-08-30 | ノバリック ゲーエムベーハー | 緑内障の治療のためのタフルプロストを含む眼科用組成物 |
| US12029757B2 (en) | 2018-09-27 | 2024-07-09 | Dermaliq Therapeutics, Inc. | Lipid barrier repair |
| JP7292567B2 (ja) | 2018-09-27 | 2023-06-19 | ダーマリック セラピューティクス， インコーポレーテッド | 局所日焼け止め製剤 |
| WO2020074697A1 (en) | 2018-10-12 | 2020-04-16 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| WO2020165132A1 (en) | 2019-02-13 | 2020-08-20 | Novaliq Gmbh | Compositions and methods for the treatment of ocular neovascularization |
| US11547714B2 (en) | 2020-02-05 | 2023-01-10 | Epalex Corporation | Fospropofol salts, methods and compositions |
| US11478490B1 (en) | 2021-03-30 | 2022-10-25 | Epalex Corporation | Fospropofol formulations |
| US11439653B1 (en) | 2021-03-30 | 2022-09-13 | Epalex Corporation | Fospropofol formulations |
| US11628178B2 (en) | 2019-03-26 | 2023-04-18 | Epalex Corporation | Fospropofol methods and compositions |
| WO2021044045A1 (en) | 2019-09-06 | 2021-03-11 | Novaliq Gmbh | Ophthalmic composition for the treatment of uveitis |
| EP3912621A1 (en) * | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Propofol for diagnosis of primary headache |
| FR3112475B1 (fr) | 2020-07-20 | 2023-11-10 | Naos Inst Of Life Science | formulation écobiologique, compatible avec la vie cellulaire, utilisable dans les domaines cosmétiques, dermopharmaceutiques ou vétérinaires |
| EP4288062A4 (en) * | 2021-02-05 | 2025-02-19 | Epalex Corporation | FOSPROPOFOL METHODS AND COMPOSITIONS |
| DE102021005494A1 (de) | 2021-11-06 | 2023-05-11 | Kocher-Plastik Maschinenbau Gmbh | Trennvorrichtung |
| DE102021005495A1 (de) | 2021-11-06 | 2023-05-11 | Kocher-Plastik Maschinenbau Gmbh | Trennvorrichtung |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5077036A (en) * | 1986-01-14 | 1991-12-31 | Alliance Pharmaceutical Corp. | Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid |
| FR2679150A1 (fr) * | 1991-07-17 | 1993-01-22 | Atta | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. |
| DE19536504C2 (de) * | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| DE19709704C2 (de) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
| EP1105096B1 (en) * | 1998-08-19 | 2003-10-29 | Skyepharma Canada Inc. | Injectable aqueous dispersions of propofol |
| US6140374A (en) | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
| WO2000054588A1 (en) | 1999-03-15 | 2000-09-21 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| US6177477B1 (en) * | 1999-03-24 | 2001-01-23 | American Home Products Corporation | Propofol formulation containing TRIS |
| US6399087B1 (en) * | 2000-12-20 | 2002-06-04 | Amphastar Pharmaceuticals, Inc. | Propofol formulation with enhanced microbial inhibition |
| US20030027833A1 (en) * | 2001-05-07 | 2003-02-06 | Cleary Gary W. | Compositions and delivery systems for administration of a local anesthetic agent |
| WO2005051305A2 (en) * | 2003-11-19 | 2005-06-09 | Barnes-Jewish Hospital | Enhanced drug delivery |
| TWI368505B (en) * | 2005-05-24 | 2012-07-21 | Wyeth Corp | Versatile high load concentrate compositions for control of ecto-parasites |
| BRPI0614084A2 (pt) | 2005-08-05 | 2011-03-09 | Bharat Serums & Vaccines Ltd | composição estável de emulsão de óleo-em-água de propofol, administrável por via intranovesa; e processo de preparação de uma composição |
| TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| DK2110126T3 (da) | 2008-04-18 | 2012-02-27 | Novaliq Gmbh | Inhalations- og instillationsanvendelse af semifluorerede alkaner som aktiv bestanddel-bærere inden for det intrapulmonale område |
-
2012
- 2012-01-03 AU AU2012204932A patent/AU2012204932B2/en active Active
- 2012-01-03 BR BR112013016661-4A patent/BR112013016661B1/pt active IP Right Grant
- 2012-01-03 DK DK12700455.4T patent/DK2661280T3/en active
- 2012-01-03 WO PCT/EP2012/050043 patent/WO2012093113A1/en not_active Ceased
- 2012-01-03 DK DK17159788.3T patent/DK3202421T3/en active
- 2012-01-03 ES ES12700455T patent/ES2711760T3/es active Active
- 2012-01-03 JP JP2013546732A patent/JP6073244B2/ja not_active Expired - Fee Related
- 2012-01-03 US US13/978,334 patent/US20140004197A1/en not_active Abandoned
- 2012-01-03 CA CA2819988A patent/CA2819988C/en active Active
- 2012-01-03 ES ES17159788.3T patent/ES2675242T3/es active Active
- 2012-01-03 PT PT171597883T patent/PT3202421T/pt unknown
- 2012-01-03 KR KR1020137018703A patent/KR101910213B1/ko active Active
- 2012-01-03 PT PT12700455T patent/PT2661280T/pt unknown
- 2012-01-03 TR TR2018/08752T patent/TR201808752T4/tr unknown
- 2012-01-03 PL PL12700455T patent/PL2661280T3/pl unknown
- 2012-01-03 PL PL17159788T patent/PL3202421T3/pl unknown
- 2012-01-03 EP EP17159788.3A patent/EP3202421B1/en active Active
- 2012-01-03 EP EP12700455.4A patent/EP2661280B1/en not_active Not-in-force
- 2012-01-03 TR TR2019/01309T patent/TR201901309T4/tr unknown
- 2012-01-03 MX MX2013007807A patent/MX353154B/es active IP Right Grant
- 2012-01-03 CN CN201280004613.1A patent/CN103313729B/zh active Active
-
2017
- 2017-04-19 US US15/491,521 patent/US20170216204A1/en not_active Abandoned
-
2019
- 2019-01-28 US US16/259,037 patent/US20190224123A1/en not_active Abandoned
-
2020
- 2020-04-30 US US16/863,918 patent/US20200360285A1/en not_active Abandoned
-
2022
- 2022-12-23 US US18/146,306 patent/US20230139672A1/en not_active Abandoned
-
2025
- 2025-07-18 US US19/274,087 patent/US20250345276A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3202421T3 (pl) | Emulsje o/w zawierające semifluorowane alkany | |
| DK2744810T4 (da) | Tenofovir-alafenamid-hemifumarat | |
| EP2715659A4 (en) | ABOUT FEED | |
| DK2769050T3 (da) | Propsensor | |
| DE102011100082A8 (de) | Traygreifvorrichtung | |
| BR112014012016A2 (pt) | compostos | |
| EP2752374A4 (en) | gooseneck | |
| EP2795884A4 (en) | Audio conferencing | |
| DK3272861T3 (da) | Alpha-galactosidase-sammensætninger | |
| EP2701512A4 (en) | Aldosterone synthase inhibitors | |
| CO6960543A2 (es) | 2-tiopirimidinonas | |
| EP2786752A4 (en) | Ropinirole-containing adhesive patch | |
| EP2723481A4 (en) | FLOW COMPENSATOR | |
| DK3141251T3 (da) | Koloskopi - forberedelse | |
| EP2708561A4 (en) | BIO-PIN | |
| EP2715068A4 (en) | Tunneling apparatus | |
| EP2695208A4 (en) | MICRO THERMOCOUPLE | |
| EP2762923A4 (en) | RADIATION MEASURING DEVICE | |
| EP2738148A4 (en) | RECIPROCAL LOCKING BLOCK | |
| DE112011104936A5 (de) | Stanzstauchniet | |
| EP2760803A4 (en) | Geopolymer product | |
| DE112012000958A5 (de) | Handsäge | |
| EP2771685A4 (en) | BIOMARKERS OF CANCER | |
| EP2729467A4 (en) | CRYPTATE COMPOUNDS | |
| EP2698098A4 (en) | campimeter |